×
Agape ATP EBITDA 2021-2025 | ATPC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Agape ATP ebitda from 2021 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
Agape ATP EBITDA 2021-2025 | ATPC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Agape ATP ebitda from 2021 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$225.2B
Boston Scientific (BSX)
$151.9B
Stryker (SYK)
$144.9B
EssilorLuxottica (ESLOY)
$142.5B
Medtronic (MDT)
$119.1B
Lonza Group Ag (LZAGY)
$48B
Haleon (HLN)
$43.5B
ResMed (RMD)
$42.2B
GE HealthCare Technologies (GEHC)
$34.4B
Agilent Technologies (A)
$34.2B
Terumo (TRUMY)
$27.9B
Koninklijke Philips (PHG)
$26.3B
Insulet (PODD)
$21.7B
Zimmer Biomet Holdings (ZBH)
$20.4B
Smith & Nephew SNATS (SNN)
$16.1B
Baxter (BAX)
$12.4B
Sunny Optical Technology (SNPTF)
$10.8B
Demant (WILYY)
$8.1B
Bio-Rad Laboratories (BIO)
$7.8B
Lantheus Holdings (LNTH)
$3.7B
Envista Holdings (NVST)
$3.6B
Shandong Weigao Medical Polymer (SHWGF)
$3.5B
Prestige Consumer Healthcare (PBH)
$3.3B
Perrigo (PRGO)
$3.3B
ICU Medical (ICUI)
$2.8B
Haemonetics (HAE)
$2.6B
LeMaitre Vascular (LMAT)
$2.2B
Curaleaf Holdings (CURLF)
$2.1B
Green Thumb Industries (GTBIF)
$1.9B
QuidelOrtho (QDEL)
$1.8B